Aims: This retrospective cohort study aimed to investigate the impact of pay-for-performance programs (P4P) on hospitalization rates in individuals with type 1 diabetes mellitus (T1D).
Methods: Using propensity score matching, we recruited 625 pairs of individuals with T1D with and without P4P care from the National Health Insurance Research Database of Taiwan between January 1, 2006, and December 31, 2018. The study used a multivariable Cox regression model to compare the risks of hospitalization for various reasons in individuals with T1D with and without P4P care.
Results: Individuals with T1D receiving pay-for-performance (P4P) care demonstrated a significantly lower risk of all-cause hospitalization (adjusted hazard ratio [aHR] 0.63, 95 % confidence interval [CI] 0.54-0.73). This reduction was particularly notable for hospitalizations related to glucose management or metabolic disorders, infectious diseases, pneumonia, circulatory and respiratory system diseases, and mental health, compared with those not receiving P4P care. However, no significant differences were observed in hospitalization risks for hyperglycemic crisis, severe hypoglycemia, or injury between individuals with and without P4P care.
Conclusions: This nationwide cohort study found that P4P participation was associated with a lower risk of hospitalization in individuals with type 1 diabetes.
{"title":"The impact of pay-for-performance programs on hospitalization risks in subjects with type 1 diabetes mellitus: A nationwide cohort study.","authors":"Yun-Kai Yeh, Fu-Shun Yen, James Cheng-Chung Wei, Yi-Ting Tsai, Heng-Jun Lin, Ying-Hsiu Shih, Chih-Cheng Hsu, Chii-Min Hwu","doi":"10.1016/j.pcd.2025.11.011","DOIUrl":"https://doi.org/10.1016/j.pcd.2025.11.011","url":null,"abstract":"<p><strong>Aims: </strong>This retrospective cohort study aimed to investigate the impact of pay-for-performance programs (P4P) on hospitalization rates in individuals with type 1 diabetes mellitus (T1D).</p><p><strong>Methods: </strong>Using propensity score matching, we recruited 625 pairs of individuals with T1D with and without P4P care from the National Health Insurance Research Database of Taiwan between January 1, 2006, and December 31, 2018. The study used a multivariable Cox regression model to compare the risks of hospitalization for various reasons in individuals with T1D with and without P4P care.</p><p><strong>Results: </strong>Individuals with T1D receiving pay-for-performance (P4P) care demonstrated a significantly lower risk of all-cause hospitalization (adjusted hazard ratio [aHR] 0.63, 95 % confidence interval [CI] 0.54-0.73). This reduction was particularly notable for hospitalizations related to glucose management or metabolic disorders, infectious diseases, pneumonia, circulatory and respiratory system diseases, and mental health, compared with those not receiving P4P care. However, no significant differences were observed in hospitalization risks for hyperglycemic crisis, severe hypoglycemia, or injury between individuals with and without P4P care.</p><p><strong>Conclusions: </strong>This nationwide cohort study found that P4P participation was associated with a lower risk of hospitalization in individuals with type 1 diabetes.</p>","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145644130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-26DOI: 10.1016/j.pcd.2025.11.008
Kristine D Gu, Daniel Shinnick, Tanayott Thaweethai, Jessica Cheng, Deborah J Wexler, Anne N Thorndike
Aims: Low-income adults face barriers to diabetes prevention and self-management, especially healthy eating. This study assessed factors associated with diet quality in low-income adults with prediabetes or type 2 diabetes (T2D), particularly modifiable factors that could be targeted in diabetes self-management education and support (DSMES).
Methods: This secondary analysis of a cohort of low-income health center patients in Boston, Massachusetts determined the association between diet quality and sociodemographic (e.g., race/ethnicity, social support) and behavioral (e.g., depression) factors in adults with prediabetes or T2D. Primary outcome was Healthy Eating Index-2020 (HEI; range 0-100, higher=healthier). Random forests, interpreted using Shapley Additive Explanation values, were fit to determine relative importance of factors in predicting HEI.
Results: Of 278 participants, 42 % had prediabetes and 58 % had T2D. Median age (IQR) was 52 (43, 57); 58 % were Hispanic. Top factors associated with higher HEI were older age, female gender, and Hispanic ethnicity; other important factors were non-smoking, greater dietary variety, less time sitting, higher sleep quality, lower stress, more social support, and fewer depression symptoms.
Conclusion: Modifiable factors for low diet quality, such as dietary variety, social support, and stress, could be emphasized in diabetes prevention and DSMES programs tailored for low-income populations.
{"title":"Sociodemographic and behavioral factors associated with diet quality in low-income adults with prediabetes and type 2 diabetes.","authors":"Kristine D Gu, Daniel Shinnick, Tanayott Thaweethai, Jessica Cheng, Deborah J Wexler, Anne N Thorndike","doi":"10.1016/j.pcd.2025.11.008","DOIUrl":"https://doi.org/10.1016/j.pcd.2025.11.008","url":null,"abstract":"<p><strong>Aims: </strong>Low-income adults face barriers to diabetes prevention and self-management, especially healthy eating. This study assessed factors associated with diet quality in low-income adults with prediabetes or type 2 diabetes (T2D), particularly modifiable factors that could be targeted in diabetes self-management education and support (DSMES).</p><p><strong>Methods: </strong>This secondary analysis of a cohort of low-income health center patients in Boston, Massachusetts determined the association between diet quality and sociodemographic (e.g., race/ethnicity, social support) and behavioral (e.g., depression) factors in adults with prediabetes or T2D. Primary outcome was Healthy Eating Index-2020 (HEI; range 0-100, higher=healthier). Random forests, interpreted using Shapley Additive Explanation values, were fit to determine relative importance of factors in predicting HEI.</p><p><strong>Results: </strong>Of 278 participants, 42 % had prediabetes and 58 % had T2D. Median age (IQR) was 52 (43, 57); 58 % were Hispanic. Top factors associated with higher HEI were older age, female gender, and Hispanic ethnicity; other important factors were non-smoking, greater dietary variety, less time sitting, higher sleep quality, lower stress, more social support, and fewer depression symptoms.</p><p><strong>Conclusion: </strong>Modifiable factors for low diet quality, such as dietary variety, social support, and stress, could be emphasized in diabetes prevention and DSMES programs tailored for low-income populations.</p>","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145644188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-25DOI: 10.1016/j.pcd.2025.11.005
Mustafa Kahraman, Ummu Mutlu, Hasan Ediz Ozbek, Elif Beyza Boz, Ramazan Cakmak, Serkan Kurt, Hatice Vildan Dudukcu, Huseyin Yildiz, Mehmet Ali Erturk, Gokhan Ozogur, Hatice Nizam Ozogur, Muhammed Ali Aydin, Nizamettin Aydin, Sukru Ozturk, Kubilay Karsidag, Ilhan Satman, Mehmet Akif Karan
Aim: The purpose of this study is to evaluate the applicability and efficacy of the Synchronized Diabetes Monitoring System (SDMs), which consists of a smart cap attached to insulin pens with recording, alarm, alert, and reminder functions, and software that operates via Bluetooth, in patients with type 2 diabetes on insulin treatment.
Methods: The system consists of a smart mobile apparatus mounted on an insulin pen and automatically recording the dose and time of the administered insulin, an application developed for mobile phones that can read blood glucose results from the glucometer, and a website.
Results: The system has been tested in a 6-month pilot cohort of SDMs group (n = 23, 44 % female, age: 50.1 ± 13 years, duration: 12.2 ± 9.2 years) in a transparent, controlled, and single-center pilot trial, showing promising results. The results were compared to the control group (n = 23, age: 54 ± 9.3 years, 52 % female, duration: 13.8 ± 7.4 years). In the third month, we found that they had better glycemic control, as indicated by a decrease in fasting blood glucose (from 147 to 114 mg/dL, p = 0.024) and HbA1c levels (from 8.5 % to 7.2 %, p = 0.003). Additionally, improvements were achieved in physical function, role limitation, and physical and mental health domains of SF-36 survey in patients using the system.
Conclusion: The preliminary results from this pilot study suggest that the synchronized diabetes monitoring system have the potential to improve glycemic control and increase health satisfaction in insulin-treated patients with type 2 diabetes.
{"title":"Efficacy of synchronized diabetes monitoring system in patients with type 2 diabetes: Preliminary results of a pilot, randomized clinical trial.","authors":"Mustafa Kahraman, Ummu Mutlu, Hasan Ediz Ozbek, Elif Beyza Boz, Ramazan Cakmak, Serkan Kurt, Hatice Vildan Dudukcu, Huseyin Yildiz, Mehmet Ali Erturk, Gokhan Ozogur, Hatice Nizam Ozogur, Muhammed Ali Aydin, Nizamettin Aydin, Sukru Ozturk, Kubilay Karsidag, Ilhan Satman, Mehmet Akif Karan","doi":"10.1016/j.pcd.2025.11.005","DOIUrl":"10.1016/j.pcd.2025.11.005","url":null,"abstract":"<p><strong>Aim: </strong>The purpose of this study is to evaluate the applicability and efficacy of the Synchronized Diabetes Monitoring System (SDMs), which consists of a smart cap attached to insulin pens with recording, alarm, alert, and reminder functions, and software that operates via Bluetooth, in patients with type 2 diabetes on insulin treatment.</p><p><strong>Methods: </strong>The system consists of a smart mobile apparatus mounted on an insulin pen and automatically recording the dose and time of the administered insulin, an application developed for mobile phones that can read blood glucose results from the glucometer, and a website.</p><p><strong>Results: </strong>The system has been tested in a 6-month pilot cohort of SDMs group (n = 23, 44 % female, age: 50.1 ± 13 years, duration: 12.2 ± 9.2 years) in a transparent, controlled, and single-center pilot trial, showing promising results. The results were compared to the control group (n = 23, age: 54 ± 9.3 years, 52 % female, duration: 13.8 ± 7.4 years). In the third month, we found that they had better glycemic control, as indicated by a decrease in fasting blood glucose (from 147 to 114 mg/dL, p = 0.024) and HbA1c levels (from 8.5 % to 7.2 %, p = 0.003). Additionally, improvements were achieved in physical function, role limitation, and physical and mental health domains of SF-36 survey in patients using the system.</p><p><strong>Conclusion: </strong>The preliminary results from this pilot study suggest that the synchronized diabetes monitoring system have the potential to improve glycemic control and increase health satisfaction in insulin-treated patients with type 2 diabetes.</p>","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145608210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-22DOI: 10.1016/j.pcd.2025.11.004
Sammra Maqsood, Saiqa Amjad, Faiyaz Ahmed, Md Faruque Ahmad
Background: A new feeding strategy called time-restricted eating (TRE) is being developed with the goal to remedy obesity and type 2 diabetes by aligning food consumption with the body's endogenous circadian rhythms. These rhythms regulate metabolic function on a daily 24-hour basis by exerting a significant impact on energy balance, lipid metabolism, and glucose homeostasis.
Methods: These databases were searched in an exhaustive manner: Scopus, Web of Science, Google Scholar, PubMed, Saudi Digital Library, and the Cochrane Library; the search was widened until January 2025. Essential search terms were: dieting on time constraint, metabolic health, the circadian rhythm, obesity, and diabetes.
Results: To optimize metabolic health, TRE takes advantage of circadian rhythms by restricting daily calorie consumption to a specified time window. TRE has been shown in clinical trials to enhance weight loss, insulin sensitivity, and glucose metabolism. Clinical evidence indicates that TRE can alter the disease trajectory of obese patients as well as patients with type 2 diabetes. The psychological and behavioral determinants of compliance with this intervention are also addressed in this review.
Conclusion: For the control of metabolic disease, TRE holds promise. For more insight into the therapeutic benefit of TRE, future studies should investigate its possible combination with individualized nutritional regimens and its long-term impact on metabolic and psychological health.
背景:一种名为限时饮食(TRE)的新喂养策略正在开发中,其目标是通过使食物摄入与人体内源性昼夜节律相一致来治疗肥胖和2型糖尿病。这些节律通过对能量平衡、脂质代谢和葡萄糖稳态产生重大影响,每天24小时调节代谢功能。方法:全面检索Scopus、Web of Science、谷歌Scholar、PubMed、Saudi Digital Library和Cochrane Library;搜索范围扩大到2025年1月。基本搜索词是:限时节食、代谢健康、昼夜节律、肥胖和糖尿病。结果:为了优化代谢健康,TRE利用昼夜节律将每日卡路里消耗限制在特定的时间窗内。在临床试验中,TRE已被证明可以促进减肥、胰岛素敏感性和葡萄糖代谢。临床证据表明,TRE可以改变肥胖患者和2型糖尿病患者的疾病轨迹。依从性的心理和行为决定因素也在这篇综述中讨论。结论:对代谢性疾病的控制有一定的应用前景。为了更深入地了解TRE的治疗益处,未来的研究应探讨其与个性化营养方案的可能组合及其对代谢和心理健康的长期影响。
{"title":"Time-restricted eating and circadian rhythms: A new frontier in diabetes and obesity management.","authors":"Sammra Maqsood, Saiqa Amjad, Faiyaz Ahmed, Md Faruque Ahmad","doi":"10.1016/j.pcd.2025.11.004","DOIUrl":"https://doi.org/10.1016/j.pcd.2025.11.004","url":null,"abstract":"<p><strong>Background: </strong>A new feeding strategy called time-restricted eating (TRE) is being developed with the goal to remedy obesity and type 2 diabetes by aligning food consumption with the body's endogenous circadian rhythms. These rhythms regulate metabolic function on a daily 24-hour basis by exerting a significant impact on energy balance, lipid metabolism, and glucose homeostasis.</p><p><strong>Methods: </strong>These databases were searched in an exhaustive manner: Scopus, Web of Science, Google Scholar, PubMed, Saudi Digital Library, and the Cochrane Library; the search was widened until January 2025. Essential search terms were: dieting on time constraint, metabolic health, the circadian rhythm, obesity, and diabetes.</p><p><strong>Results: </strong>To optimize metabolic health, TRE takes advantage of circadian rhythms by restricting daily calorie consumption to a specified time window. TRE has been shown in clinical trials to enhance weight loss, insulin sensitivity, and glucose metabolism. Clinical evidence indicates that TRE can alter the disease trajectory of obese patients as well as patients with type 2 diabetes. The psychological and behavioral determinants of compliance with this intervention are also addressed in this review.</p><p><strong>Conclusion: </strong>For the control of metabolic disease, TRE holds promise. For more insight into the therapeutic benefit of TRE, future studies should investigate its possible combination with individualized nutritional regimens and its long-term impact on metabolic and psychological health.</p>","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145590610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-21DOI: 10.1016/j.pcd.2025.11.009
Döndü Bilici, Meryem Kılıç
Background: Frailty is increasingly recognized as a condition that negatively affects self-management in individuals with type 2 diabetes. Limited evidence exists regarding its impact on diabetic foot self-care and self-efficacy, particularly in middle-aged populations.
Objectives: This study aimed to examine the effect of frailty on foot care behaviors and self-efficacy among middle-aged and older adults with type 2 diabetes.
Methods: A descriptive, cross-sectional study was conducted with 75 middle-aged (40-64 years) and 75 older (≥65 years) adults diagnosed with type 2 diabetes. Data were collected using the FRAIL Scale, the Foot Care Behavior Scale, and the Diabetic Foot Care Self-Efficacy Scale. Group comparisons were performed using independent t-tests, and regression analyses were used to evaluate the predictive role of frailty.
Results: Frailty prevalence was 22.7 % in middle-aged adults and 42.7 % in older adults. Regression analyses showed that frailty was a strong predictor of both self-efficacy and foot care behaviors. Each one-point increase in frailty score was associated with a ∼12-point decrease in self-efficacy (β=-0.876; p < 0.001) and an ∼8-point decrease in foot care behaviors (β=-0.905; p < 0.001). The explanatory power of frailty was greater in middle-aged adults compared to older adults.
Conclusion: Frailty significantly impairs foot care behaviors and self-efficacy in adults with type 2 diabetes. Routine frailty screening, even from middle age, may support the early identification of individuals at risk for diabetic foot complications and inform preventive wound care strategies.
背景:虚弱越来越被认为是对2型糖尿病患者自我管理产生负面影响的一种状况。关于它对糖尿病足自我保健和自我效能的影响,特别是在中年人群中,证据有限。目的:本研究旨在探讨虚弱对中老年2型糖尿病患者足部护理行为和自我效能感的影响。方法:对75名诊断为2型糖尿病的中年人(40-64岁)和75名老年人(≥65岁)进行描述性横断面研究。采用体弱量表、足部护理行为量表和糖尿病足部护理自我效能量表收集数据。采用独立t检验进行组间比较,并采用回归分析评估虚弱的预测作用。结果:中老年人和老年人的衰弱患病率分别为22.7% %和42.7% %。回归分析显示,虚弱是自我效能感和足部护理行为的强预测因子。虚弱评分每增加1分,自我效能感就会降低~ 12分(β=-0.876; p )。结论:虚弱显著影响2型糖尿病成人足部护理行为和自我效能感。常规虚弱筛查,甚至从中年开始,可以支持早期识别有糖尿病足并发症风险的个体,并告知预防性伤口护理策略。
{"title":"Impact of frailty on foot care behaviors and self-efficacy in middle-aged and older adults with type 2 diabetes.","authors":"Döndü Bilici, Meryem Kılıç","doi":"10.1016/j.pcd.2025.11.009","DOIUrl":"https://doi.org/10.1016/j.pcd.2025.11.009","url":null,"abstract":"<p><strong>Background: </strong>Frailty is increasingly recognized as a condition that negatively affects self-management in individuals with type 2 diabetes. Limited evidence exists regarding its impact on diabetic foot self-care and self-efficacy, particularly in middle-aged populations.</p><p><strong>Objectives: </strong>This study aimed to examine the effect of frailty on foot care behaviors and self-efficacy among middle-aged and older adults with type 2 diabetes.</p><p><strong>Methods: </strong>A descriptive, cross-sectional study was conducted with 75 middle-aged (40-64 years) and 75 older (≥65 years) adults diagnosed with type 2 diabetes. Data were collected using the FRAIL Scale, the Foot Care Behavior Scale, and the Diabetic Foot Care Self-Efficacy Scale. Group comparisons were performed using independent t-tests, and regression analyses were used to evaluate the predictive role of frailty.</p><p><strong>Results: </strong>Frailty prevalence was 22.7 % in middle-aged adults and 42.7 % in older adults. Regression analyses showed that frailty was a strong predictor of both self-efficacy and foot care behaviors. Each one-point increase in frailty score was associated with a ∼12-point decrease in self-efficacy (β=-0.876; p < 0.001) and an ∼8-point decrease in foot care behaviors (β=-0.905; p < 0.001). The explanatory power of frailty was greater in middle-aged adults compared to older adults.</p><p><strong>Conclusion: </strong>Frailty significantly impairs foot care behaviors and self-efficacy in adults with type 2 diabetes. Routine frailty screening, even from middle age, may support the early identification of individuals at risk for diabetic foot complications and inform preventive wound care strategies.</p>","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145582496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-21DOI: 10.1016/j.pcd.2025.11.007
Ayokunle Osonuga, Gloria Okoye, Adewoyin Osonuga, Serge Engamba, Nicholas Aderinto
Background: Prediabetes, marked by elevated blood glucose levels below the type 2 diabetes mellitus (T2DM) threshold, is a growing public health concern due to its rising prevalence and risk of progression to diabetes and cardiovascular issues. Structured weight loss programs in primary care show promise for improving glycemic control, yet their impact on HbA1c remains underexplored. This systematic review evaluates their effectiveness in reducing HbA1c in adults with prediabetes.
Methods: Following the 2020 PRISMA and SWiM guidelines, we searched six databases (PubMed, EMBASE, Cochrane CENTRAL, Scopus, CINAHL, Web of Science) up to July 10, 2025, for studies on structured weight loss programs in primary care. Eligible studies involved adults (≥18 years) with prediabetes, using RCTs, cohort studies, or pilot interventions with HbA1c as the primary outcome. Data were extracted, and risk of bias was assessed using Cochrane RoB 2.0 and ROBINS-I tools. A narrative synthesis was performed due to study heterogeneity.
Results: Seven studies (n = 43-2227) showed HbA1c reductions of 0.03 %-0.83 %, with high-intensity (e.g., frequent behavioral sessions) and digital interventions (e.g., low-carbohydrate apps) yielding the largest effects. Weight loss (up to 7.2 kg), BMI, and lipid profiles also improved. Adherence and intervention intensity were key factors, though inconsistent reporting limited comparisons.
Conclusion: Structured weight loss programs in primary care are consistently associated with modest-to-moderate HbA1c reductions, with high-intensity and digital interventions showing the greatest promise. However, study heterogeneity and inconsistent adherence reporting limit definitive conclusions. Future research should prioritize standardized reporting, long-term outcomes, and diverse populations to enhance generalizability.
背景:前驱糖尿病,以血糖水平升高低于2型糖尿病(T2DM)阈值为标志,由于其患病率和进展为糖尿病和心血管问题的风险不断上升,是一个日益严重的公共卫生问题。初级保健中有组织的减肥计划有望改善血糖控制,但其对HbA1c的影响仍未得到充分探讨。本系统综述评估了它们在降低成人糖尿病前期患者HbA1c方面的有效性。方法:根据2020年PRISMA和SWiM指南,我们检索了六个数据库(PubMed, EMBASE, Cochrane CENTRAL, Scopus, CINAHL, Web of Science),截至2025年7月10日,用于初级保健结构化减肥计划的研究。符合条件的研究涉及成人(≥18岁)前驱糖尿病患者,采用随机对照试验、队列研究或以HbA1c为主要结局的试点干预。提取资料,使用Cochrane RoB 2.0和ROBINS-I工具评估偏倚风险。由于研究的异质性,我们进行了叙事综合。结果:七项研究(n = 43-2227)显示,HbA1c降低0.03% %-0.83 %,高强度(如频繁的行为会话)和数字干预(如低碳水化合物应用程序)产生的效果最大。体重减轻(高达7.2 kg)、BMI和脂质谱也有所改善。依从性和干预强度是关键因素,尽管不一致的报告限制了比较。结论:初级保健中有组织的减肥计划始终与中度至中度HbA1c降低相关,高强度和数字化干预显示出最大的希望。然而,研究的异质性和不一致的依从性报告限制了明确的结论。未来的研究应优先考虑标准化报告、长期结果和多样化人群,以提高普遍性。
{"title":"A systematic review of structured weight loss programs and their association with HbA1c reduction in adults with prediabetes managed in primary care.","authors":"Ayokunle Osonuga, Gloria Okoye, Adewoyin Osonuga, Serge Engamba, Nicholas Aderinto","doi":"10.1016/j.pcd.2025.11.007","DOIUrl":"https://doi.org/10.1016/j.pcd.2025.11.007","url":null,"abstract":"<p><strong>Background: </strong>Prediabetes, marked by elevated blood glucose levels below the type 2 diabetes mellitus (T2DM) threshold, is a growing public health concern due to its rising prevalence and risk of progression to diabetes and cardiovascular issues. Structured weight loss programs in primary care show promise for improving glycemic control, yet their impact on HbA1c remains underexplored. This systematic review evaluates their effectiveness in reducing HbA1c in adults with prediabetes.</p><p><strong>Methods: </strong>Following the 2020 PRISMA and SWiM guidelines, we searched six databases (PubMed, EMBASE, Cochrane CENTRAL, Scopus, CINAHL, Web of Science) up to July 10, 2025, for studies on structured weight loss programs in primary care. Eligible studies involved adults (≥18 years) with prediabetes, using RCTs, cohort studies, or pilot interventions with HbA1c as the primary outcome. Data were extracted, and risk of bias was assessed using Cochrane RoB 2.0 and ROBINS-I tools. A narrative synthesis was performed due to study heterogeneity.</p><p><strong>Results: </strong>Seven studies (n = 43-2227) showed HbA1c reductions of 0.03 %-0.83 %, with high-intensity (e.g., frequent behavioral sessions) and digital interventions (e.g., low-carbohydrate apps) yielding the largest effects. Weight loss (up to 7.2 kg), BMI, and lipid profiles also improved. Adherence and intervention intensity were key factors, though inconsistent reporting limited comparisons.</p><p><strong>Conclusion: </strong>Structured weight loss programs in primary care are consistently associated with modest-to-moderate HbA1c reductions, with high-intensity and digital interventions showing the greatest promise. However, study heterogeneity and inconsistent adherence reporting limit definitive conclusions. Future research should prioritize standardized reporting, long-term outcomes, and diverse populations to enhance generalizability.</p>","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145582305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-18DOI: 10.1016/j.pcd.2025.11.003
Shixuan Guo, Juan Shu
{"title":"Comment on: Cognitive impairment is associated with poor diabetic foot ulcer outcomes.","authors":"Shixuan Guo, Juan Shu","doi":"10.1016/j.pcd.2025.11.003","DOIUrl":"https://doi.org/10.1016/j.pcd.2025.11.003","url":null,"abstract":"","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145558825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-07DOI: 10.1016/j.pcd.2025.11.001
Zhipeng Dou, Lele Peng
{"title":"Glycemic status and effect on mortality: Multifactorial prevention programme for cardiovascular disease in Finnish primary care.","authors":"Zhipeng Dou, Lele Peng","doi":"10.1016/j.pcd.2025.11.001","DOIUrl":"https://doi.org/10.1016/j.pcd.2025.11.001","url":null,"abstract":"","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145476838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-06DOI: 10.1016/j.pcd.2025.11.002
Himanshu Shekhar, Parth Aphale, Shashank Dokania
{"title":"Critical appraisal of \"impact of a primary care-based mobile health intervention to 'sit less and move more' on HbA1c, blood pressure, and other clinical outcomes in office employees with type 2 diabetes\".","authors":"Himanshu Shekhar, Parth Aphale, Shashank Dokania","doi":"10.1016/j.pcd.2025.11.002","DOIUrl":"https://doi.org/10.1016/j.pcd.2025.11.002","url":null,"abstract":"","PeriodicalId":94177,"journal":{"name":"Primary care diabetes","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145472557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}